- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional, Single centre
- Study aim: To estimate the prevalence of cognitive disorders, specifically "COVID fog," in the population and to assess the potential therapeutic effects of tianeptine and group psychotherapy and neurological rehabilitation on cognitive function, anxiety, and depression in COVID-19 convalescents
- Number of participants enrolled: Enrollment ongoing
- Study enrolling from to
- Study includes follow-up for 4 months
Study Data
- General population
- Elderly
- Adult
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Anti-depressant
- Tianeptine
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to